Today: 9 June 2026
Figure Technology Solutions stock (FIGR) steadies before the bell after 18% jump, lock-up looms
3 March 2026
1 min read

Figure Technology Solutions stock (FIGR) steadies before the bell after 18% jump, lock-up looms

New York, March 3, 2026, 09:15 (EST) — Premarket

  • FIGR traded at $29.72 before the bell, following a 17.6% surge on Monday.
  • Goldman Sachs lowered its 12-month price target to $44, down from $49, but is sticking with its Buy rating.
  • The post-IPO lock-up blocking insider sales is due to expire March 10

Figure Technology Solutions Inc (FIGR.O) hovered near flat in Tuesday’s premarket, last quoted at $29.72. The stock had surged 17.6% during the prior session.

The stock’s sudden jump is drawing traders’ attention again, landing it in the spotlight before a busy week packed with possible triggers. One key event: the post-IPO lock-up expires next Tuesday, which might boost the share supply.

Crypto sentiment factors in here. Bitcoin popped roughly 2.5%, trading near $67,100 during early U.S. hours.

Goldman Sachs cut its 12-month price target on Figure to $44 from $49 on Monday but stuck with a “Buy” rating, Investing.com’s analyst summary shows. That price target signals where analysts expect the stock might be a year from now. Investing.com

Late last week, the company rolled out its fourth-quarter numbers and unveiled a $200 million buyback. Chief executive Michael Tannenbaum, in the official release, emphasized the drive to “expand our partner network” as the group deepens its move into blockchain-based capital markets. GlobeNewswire

During the Feb. 26 earnings call, CFO Macrina Kgil pointed to seasonal trends, telling analysts, “We do anticipate higher growth in March,” following what she called slower winter months. MarketBeat

Figure calls itself a blockchain-native capital marketplace, connecting loan origination, funding, and secondary market activity. Its product lineup ranges from consumer credit to digital assets.

The New York-based company debuted on the public markets in September 2025, setting its IPO price at $25 per share. Shares kicked off trading at $36, closing the session with a roughly 44% gain and landing the firm’s market cap near $7.62 billion, according to Reuters.

The IPO triggered a standard lock-up, barring insiders and early investors from offloading shares right away. According to MarketBeat’s lock-up calendar, Figure insiders will see their restriction lift on March 10.

But lock-up expiries don’t always play out the same way. If sellers hit the market early, shares can come under pressure—even when sentiment is turning up. FIGR has already swung sharply both ways.

Stock Market Today

  • Soybean Prices Decline Amid Lower Export Shipments and Reduced Speculative Positions
    June 9, 2026, 9:21 AM EDT. Soybean prices fell between 2 and 5 ½ cents on Monday, with the national average cash price dropping to $10.58 3/4 per bushel. Export shipments for the week ending June 4 decreased by 21.2% from the previous week, totaling 398,186 MT, and are down 28.8% year-over-year. Key buyers included Egypt, China, and Mexico. Marketing year exports stand 20.3% lower compared to last year. Meanwhile, speculative traders reduced their net long positions in soybean futures and options by 33,502 contracts, signaling cautious market sentiment. Soymeal and soy oil futures also declined modestly. A private export sale of 264,000 MT was reported for the 2026/27 season, but overall market pressure weighs on prices going into the week.

Latest articles

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

9 June 2026
Factorial Energy surged 16% to $13.80 in its Nasdaq debut as FAC, with premarket trading near $20.70, after replacing CGCT via SPAC merger that raised over $100 million for battery commercialization and implied a $1.3 billion equity value; former CGCT shares now trade as FAC, with founders retaining majority voting power and staged lock-up releases ahead.
Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

9 June 2026
Pfizer shares fell 1.7% premarket to $25.62 as investors weighed an FDA label expansion for hemophilia drug Hympavzi—now the first subcutaneous non-factor therapy for children 6-11 with hemophilia B—against slower progress in obesity drugs, with mid-stage data for weight-loss shot berobenatide showing a 23.3% vomiting rate and no immediate growth catalyst for the $147 billion company.
MARA stock jumps premarket as annual filing opens door to selling bitcoin stash
Previous Story

MARA stock jumps premarket as annual filing opens door to selling bitcoin stash

CrowdStrike stock holds steady after upbeat 2027 forecast as Wall Street sizes up ARR
Next Story

CrowdStrike stock holds steady after upbeat 2027 forecast as Wall Street sizes up ARR

Go toTop